Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Total RNA-seq in patients with hematological malignancy

ABSTRACT: Total RNA-seq in patients with hematological malignancy

PROVIDER: PRJNA486089 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR7695260.fastq.gz	Fastqsanger.gz
	SRR7695270.fastq.gz	Fastqsanger.gz
	SRR7695280.fastq.gz	Fastqsanger.gz
	SRR7695290.fastq.gz	Fastqsanger.gz
	SRR7695300.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 63

Similar Datasets

Total RNA-seq in patients with hematological malignancy

Project description:Immune response and leukocyte activation genes are upregulated following 5-azacitidine treatment

2019-08-13 | GSE118558 | GEO

A DNA methylation database of human and mouse hematological malignancy cell lines

Project description:A DNA methylation database of human and mouse hematological malignancy cell lines

| PRJNA1126749 | ENA

Comprehensive genetic analysis of Epstein-Barr virus-associated hematological malignancy

Project description:Comprehensive genetic analyses including whole-exome sequencing, targeted sequencing, and whole-genome sequencing of the human genome and the Epstein-Barr virus (EBV) genome were performed to reveal the molecular pathogenesis of EBV-associated hematological malignancy.

| EGAS00001003159 | EGA

Total RNA-Seq data from leukemic patients with complex structural variants

Project description:Total RNA-Seq data from leukemic patients with complex structural variants

| PRJNA528460 | ENA

Genomic analysis of pediatric AML by whole transcriptome sequencing [pediatric AML patients]

Project description:Pediatric AML is an aggressive hematological malignancy associated with distinctive genomic features. We employed RNA-seq to study fusion genes and clinically relevant gene expression patterns in pediatric AML patients.

2023-05-02 | GSE222814 | GEO

A DNA methylation database of human and mouse hematological malignancy cell lines

Project description:Human cancer cell lines constitute useful models to model the primary disease and many relevant findings in tumor biology have been originated from them since the first immortalized cell line (HeLa) was obtained. The easy experimental intervention, the purity of the transformed cells and their versatility to undergo high-throughput screenings represent advantageous features of the established cancer cell lines. Herein, we have obtained the DNA methylation profiles of 210 cell lines derived from hematological malignancies utilizing comprehensive DNA methylation microarrays that interrogate more than 850,000 and 285,000 CpG sites from human and mouse genomes, respectively.

2024-11-05 | GSE270494 | GEO

Defective RNA helicase genes underlie predisposition to colorectal and hematological malignancies

Project description:Background: Causative genes are mostly unknown for the mismatch repair-proficient category of familial colorectal cancers designated as FCCTX. Recent evidence suggests shared susceptibility factors between colorectal and hematological malignancies. Study design: We investigated 28 FCCTX families by exome sequencing, supplemented with whole genome sequencing, RNA-sequencing, and tumor studies to identify the predisposing genes. Guided by the findings, germline and somatic exomes of ~400 patients with acute leukemia, myelodysplastic syndrome, and myeloma were subsequently examined. Results: A family with hematological and solid malignancies revealed a truncating variant in the DEAH-box RNA helicase gene DHX40 co-segregating with disease in seven family members. Neoplastic tissues revealed no apparent “second hit”, implying a haploinsufficiency model of tumorigenesis. DHX40 siRNA-treated cell lines exhibited a 13% increase in aberrantly spliced transcripts vs. GAPDH-siRNA or non-target siRNA-treated cells. Two additional families showed truncating germline variants in the TDRD9 and TDRD5 genes encoding Tudor domain-containing RNA-binding proteins. In the hospital-based hematological series, 18% of germline and 28% of somatic exomes revealed possibly pathogenic DEAD/H box gene variants, including somatic variants of DHX40 in four. Conclusions: This study identifies DHX40, TDRD9, and TDRD5 as novel candidate genes for FCCTX predisposition. In the family segregating the truncating DHX40 variant, two carriers had hematological neoplasia, suggesting possible analogy to DDX41, a DEAD-box RNA helicase gene previously linked to myeloid malignancies. Our findings emphasize aberrant RNA metabolism behind FCCTX and hematological neoplasia.

2023-11-08 | GSE228991 | GEO

Single cell profiling of total RNA using Smart-seq-total

Project description:Single cell profiling of total RNA using Smart-seq-total

| PRJNA635600 | ENA

germline variants in children with hematological cancer

Project description:Trio parent-child whole exome sequencing has been used to identify cancer predisposing syndrome (CPS) in our pediatric patients with hematological cancer, and it was identified in 3.8% of the total number of patients(131).

| EGAS00001006907 | EGA

Surface water total RNA-seq

Project description:Surface water total RNA-seq Raw sequence reads

| PRJNA503551 | ENA